ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas (ALBATROSS)
Sponsor: Azienda Ospedaliero-Universitaria di Parma
This observational or N/A phase trial investigates Astrocytoma, Grade IV and is currently completed. Azienda Ospedaliero-Universitaria di Parma leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Aug 2025 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Aug 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Mar 2022 — Mar 2024 [monthly]
Recruiting
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero-Universitaria di Parma
- Centre Hospitalier Universitaire de Liege
- Hospital Clinic of Barcelona
- Hospital Vall d'Hebron
- Hospital de Manises
- Hospital de la Ribera
- Juan M Garcia-Gomez
- Oslo University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .